← The Wire
CRNXNasdaq
Crinetics Pharmaceuticals, Inc.
Pharmaceutical Preparations · DE · CIK 1658247
Crinetics Pharmaceuticals discovers, develops, and commercializes novel therapies for endocrine diseases and tumors
red 8-K · 90d
$3.63B
Market cap
$36.94
Last close
+0.7%
1D
+4.4%
5D
884K
Volume
Price · last 39 sessions-10.4%
May 4L $32.61 · H $43.49Jun 29
201
Total filings
Jun 22, 2026
Last filing
12/31
Fiscal year end
SC 13GSC 13GNov 14, 2024SC 13GSEC SCHEDULE 13GNov 8, 2024SC 13GSC 13GMar 11, 2024SC 13GSCHEDULE 13GFeb 13, 2024SC 13GSC 13GFeb 9, 2024SC 13GSC 13GJan 24, 2024SC 13GCRINETICS PHARMACEUTICALS, INC.Sep 18, 2023SC 13GSC 13GFeb 14, 2023SC 13GSEC SCHEDULE 13GFeb 6, 2023SC 13GNONEJan 10, 2022SC 13GSC 13GOct 29, 2021SC 13GSC 13GApr 22, 2021SC 13GSC 13GFeb 2, 2021SC 13GSC 13GFeb 14, 2020SC 13GSC 13GFeb 11, 2020SC 13GSC 13GFeb 14, 2019SC 13GSC 13GFeb 14, 2019SC 13GSC 13GSep 10, 2018SC 13GSC 13GJul 30, 2018SC 13GSCHEDULE 13GJul 30, 2018SC 13GSC 13GJul 26, 2018
Insider Activity
In the 90 days to Mar 16, 2026: 7 sold $2.3M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 16, 2026 | Struthers Richard ScottPresident & CEO | Sell | 13,196 | $37.11 | $490K |
| Mar 16, 2026 | Struthers Richard ScottPresident & CEO | Sell | 8,785 | $37.77 | $332K |
| Mar 16, 2026 | Betz Stephen F.Chief Scientific Officer | Sell | 6,371 | $37.11 | $236K |
| Mar 16, 2026 | Knight Jeff E.Chief Operating Officer | Sell | 5,950 | $37.11 | $221K |
| Mar 16, 2026 | Betz Stephen F.Chief Scientific Officer | Sell | 4,241 | $37.77 | $160K |
| Mar 16, 2026 | Knight Jeff E.Chief Operating Officer | Sell | 3,961 | $37.77 | $150K |
| Mar 12, 2026 | Vivaldi Coelho RogerioDirector | Sell | 4,477 | $36.08 | $162K |
| Mar 12, 2026 | Vivaldi Coelho RogerioDirector | Sell | 523 | $36.77 | $19K |
| Mar 3, 2026 | Schilke TobinChief Financial Officer | Sell | 6,713 | $39.67 | $266K |
| Mar 3, 2026 | Okey StephanieDirector | Sell | 3,000 | $39.67 | $119K |
| Jan 5, 2026 | Kalofonos IsabelChief Commercial Officer | Sell | 2,500 | $55.00 | $138K |
| Dec 1, 2025 | Pizzuti DanaChief Med and Dev Officer | Sell | 5,000 | $45.02 | $225K |
| Nov 3, 2025 | Pizzuti DanaChief Med and Dev Officer | Sell | 4,900 | $42.65 | $209K |
| Nov 3, 2025 | Pizzuti DanaChief Med and Dev Officer | Sell | 100 | $43.27 | $4K |
| Oct 1, 2025 | Pizzuti DanaChief Med and Dev Officer | Sell | 5,000 | $41.81 | $209K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance